Orringer Jeffrey S, Helfrich Yolanda Rosi, Hamilton Ted, Friedman Claire, Johnson Timothy M, Sachs Dana L
Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
J Am Acad Dermatol. 2006 Mar;54(3):416-9. doi: 10.1016/j.jaad.2005.11.1067. Epub 2006 Jan 23.
Little is known about the psychologic status of cosmetically oriented dermatology patients.
We sought to determine the prevalence of psychotropic medication use among such patients to offer insight into the rates of psychopathology in this group.
We conducted a retrospective chart review of patients seeking consultation at a cosmetic dermatology practice, recorded patients' use of psychotropic medicines, and compared this with data from a control group of medical dermatology patients.
Both groups reported rates of psychotropic medication use above those expected in the general population. There was no statistically significant difference in the prevalence of psychotropic drug use between cosmetic (18%) and medical (17%) dermatology patients.
There is not a one-to-one correspondence between psychotropic medication use and the presence of psychopathology. Data are based on patient health histories and, thus, may be subject to underreporting.
There is a relatively high rate of psychotropic drug use among all patients seeking care from dermatologists, but this does not appear to be more common among patients interested in undergoing cosmetic procedures.
对于有美容需求的皮肤科患者的心理状态，我们了解甚少。
我们试图确定此类患者中使用精神药物的比例，以便深入了解该群体的精神病理学发生率。
我们对一家美容皮肤科诊所寻求咨询的患者进行了回顾性病历审查，记录患者使用精神药物的情况，并将其与一组皮肤科普通患者的数据进行比较。
两组报告的精神药物使用率均高于一般人群的预期。美容皮肤科患者（18%）和普通皮肤科患者（17%）在精神药物使用比例上无统计学显著差异。
精神药物使用与精神病理学的存在并非一一对应。数据基于患者健康史，因此可能存在报告不足的情况。
在所有寻求皮肤科治疗的患者中，精神药物使用率相对较高，但这在对美容手术感兴趣的患者中似乎并不更常见。
